磷酸化组蛋白去乙酰化酶1抗体

Quantity size:

0.1ml

Concentration:

1mg/ml磷酸化组蛋白去乙酰化酶1抗体   Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

Reversible acetylation of highly conserved lysine residues within the N-terminal tail domains of core histones, plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone acetylation is a dynamic process determined by the net activities of histone acetyltransferases (HATs) and the competing enzymes histone deacetylases (HDACs). Histone deacetylases activities are often, but not 磷酸化组蛋白去乙酰化酶1抗体 always, associated with transcriptional repression and nucleosomal condensations. Recruitment of the multiprotein complexes to promoter sites occurs by many sequence specific DNA-binding proteins such as unliganded nuclear hormone receptors, DP1-E2F, YY1 and Rb family of transcription factors, transcriptional repressors and tumor suppressors (e.g. BRCA1). Aberrant recruitment of HDACs by certain oncoproteins may occur in certain neoplastic diseases. Belongs to the histone deacetylase family. Type 1.

磷酸化组蛋白去乙酰化酶1抗体 Also known as:

HDAC1 (phospho S421 + S423); p-HDAC1 (phospho S421 + S423); dHDAC1 (phospho S421 + S423); p-dHDAC1 (phospho S421 + S423); DKFZp686H12203; GON 10; HD 1; HD1; HDAC 1; hdac1: histone deacetylase 1; Histone deacetylase 1 (HD1); Histone deacetylase 1; RPD3 (reduced potassium dependency yeast homolog) like 1; RPD3 (reduced potassium dependency); RPD3; RPD3L1; HDAC2_HUMAN.

Specificity:

●

Rabbit Polyclonal IgG,磷酸化组蛋白去乙酰化酶1抗体  affinity purified by Protein A.

●

Reacts with: Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Sheep, .

●

Immunogen: KLH conjugated Synthesised phosphopeptide derived from human.

●

Predicted Molecular Weight: 55kDa.

磷酸化组蛋白去乙酰化酶1抗体 Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.

kl768Mu01足盂蛋白(PCX)多克隆抗体Polyclonal Antibody to Podocalyxin (PCX)

kl770Hu01胱天蛋白酶5(CASP5)多克隆抗体Polyclonal Antibody to Caskle 5 (CASP5)

kl771Hu01趋化因子C-X-C-基元配体16(CXCL16)多克隆抗体Polyclonal Antibody to Chemokine C-X-C-Motif Ligand 16 (CXCL16)

kl771Ra01趋化因子C-X-C-基元配体16(CXCL16)多克隆抗体Polyclonal Antibody to Chemokine C-X-C-Motif Ligand 16 (CXCL16)

kl775Hu01己糖激酶1(HK1)多克隆抗体Polyclonal Antibody to Hexokinase 1 (HK1)

kl775Mu01己糖激酶1(HK1)多克隆抗体Polyclonal Antibody to Hexokinase 1 (HK1)

kl776Hu01丙酮酸脱氢酶α(PDHα)多克隆抗体Polyclonal Antibody to Pyruvate Dehydrogenase Alpha (PDHa)

kl776Mu01丙酮酸脱氢酶α(PDHα)多克隆抗体Polyclonal Antibody to Pyruvate Dehydrogenase Alpha (PDHa)

kl776Ra01丙酮酸脱氢酶α(PDHα)多克隆抗体Polyclonal Antibody to Pyruvate Dehydrogenase Alpha (PDHa)

kl777Hu01T-细胞可诱导共刺激分子(ICOS)多克隆抗体Polyclonal Antibody to Inducible T-Cell Co Stimulator (ICOS)

kl778Hu01B-细胞淋巴瘤因子2(Bcl2)多克隆抗体Polyclonal Antibody to B-Cell Leukemia/Lymphoma 2 (Bcl2)

kl778Mu01B-细胞淋巴瘤因子2(Bcl2)多克隆抗体Polyclonal Antibody to B-Cell Leukemia/Lymphoma 2 (Bcl2)

kl778Po01B-细胞淋巴瘤因子2(Bcl2)多克隆抗体Polyclonal Antibody to B-Cell Leukemia/Lymphoma 2 (Bcl2)

kl778Ra01B-细胞淋巴瘤因子2(Bcl2)多克隆抗体Polyclonal Antibody to B-Cell Leukemia/Lymphoma 2 (Bcl2)

kl781Hu01CD276分子(CD276)多克隆抗体Polyclonal Antibody to Cluster Of Differentiation 276 (CD276)

kl782Ga01碳酸酐酶Ⅱ(CA2)多克隆抗体Polyclonal Antibody to Carbonic Anhydrase II (CA2)

kl782Hu01碳酸酐酶Ⅱ(CA2)多克隆抗体Polyclonal Antibody to Carbonic Anhydrase II (CA2)

kl783Hu01补体因子P(CFP)多克隆抗体Polyclonal Antibody to Complement Factor P (CFP)

kl785Hu01肾损伤分子1(Kim1)多克隆抗体Polyclonal Antibody to Kidney Injury Molecule 1 (Kim1)

kl785Mu01肾损伤分子1(Kim1)多克隆抗体Polyclonal Antibody to Kidney Injury Molecule 1 (Kim1)

kl785Ra01肾损伤分子1(Kim1)多克隆抗体Polyclonal Antibody to Kidney Injury Molecule 1 (Kim1)

kl786Hu01纤维胶凝蛋白1(FCN1)多克隆抗体Polyclonal Antibody to Ficolin 1 (FCN1)